Cargando…
High throughput nanopore sequencing of SARS-CoV-2 viral genomes from patient samples
In late 2019, a novel coronavirus began spreading in Wuhan, China, causing a potentially lethal respiratory viral infection. By early 2020, the novel coronavirus, called SARS-CoV-2, had spread globally, causing the COVID-19 pandemic. The infection and mutation rates of SARS-CoV-2 make it amenable to...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Journal of Biological Methods
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8493558/ https://www.ncbi.nlm.nih.gov/pubmed/34631911 http://dx.doi.org/10.14440/jbm.2021.360 |
_version_ | 1784579137535475712 |
---|---|
author | Pater, Adrian A. Bosmeny, Michael S. White, Adam A. Sylvain, Rourke J. Eddington, Seth B. Parasrampuria, Mansi Ovington, Katy N. Metz, Paige E. Yinusa, Abadat O. Barkau, Christopher L. Chilamkurthy, Ramadevi Benzinger, Scott W. Hebert, Madison. M. Gagnon, Keith T. |
author_facet | Pater, Adrian A. Bosmeny, Michael S. White, Adam A. Sylvain, Rourke J. Eddington, Seth B. Parasrampuria, Mansi Ovington, Katy N. Metz, Paige E. Yinusa, Abadat O. Barkau, Christopher L. Chilamkurthy, Ramadevi Benzinger, Scott W. Hebert, Madison. M. Gagnon, Keith T. |
author_sort | Pater, Adrian A. |
collection | PubMed |
description | In late 2019, a novel coronavirus began spreading in Wuhan, China, causing a potentially lethal respiratory viral infection. By early 2020, the novel coronavirus, called SARS-CoV-2, had spread globally, causing the COVID-19 pandemic. The infection and mutation rates of SARS-CoV-2 make it amenable to tracking introduction, spread and evolution by viral genome sequencing. Efforts to develop effective public health policies, therapeutics, or vaccines to treat or prevent COVID-19 are also expected to benefit from tracking mutations of the SARS-CoV-2 virus. Here we describe a set of comprehensive working protocols, from viral RNA extraction to analysis using established visualization tools, for high throughput sequencing of SARS-CoV-2 viral genomes using a MinION instrument. This set of protocols should serve as a reliable “how-to” reference for generating quality SARS-CoV-2 genome sequences with ARTIC primer sets and long-read nanopore sequencing technology. In addition, many of the preparation, quality control, and analysis steps will be generally applicable to other sequencing platforms. |
format | Online Article Text |
id | pubmed-8493558 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Journal of Biological Methods |
record_format | MEDLINE/PubMed |
spelling | pubmed-84935582021-10-07 High throughput nanopore sequencing of SARS-CoV-2 viral genomes from patient samples Pater, Adrian A. Bosmeny, Michael S. White, Adam A. Sylvain, Rourke J. Eddington, Seth B. Parasrampuria, Mansi Ovington, Katy N. Metz, Paige E. Yinusa, Abadat O. Barkau, Christopher L. Chilamkurthy, Ramadevi Benzinger, Scott W. Hebert, Madison. M. Gagnon, Keith T. J Biol Methods Article In late 2019, a novel coronavirus began spreading in Wuhan, China, causing a potentially lethal respiratory viral infection. By early 2020, the novel coronavirus, called SARS-CoV-2, had spread globally, causing the COVID-19 pandemic. The infection and mutation rates of SARS-CoV-2 make it amenable to tracking introduction, spread and evolution by viral genome sequencing. Efforts to develop effective public health policies, therapeutics, or vaccines to treat or prevent COVID-19 are also expected to benefit from tracking mutations of the SARS-CoV-2 virus. Here we describe a set of comprehensive working protocols, from viral RNA extraction to analysis using established visualization tools, for high throughput sequencing of SARS-CoV-2 viral genomes using a MinION instrument. This set of protocols should serve as a reliable “how-to” reference for generating quality SARS-CoV-2 genome sequences with ARTIC primer sets and long-read nanopore sequencing technology. In addition, many of the preparation, quality control, and analysis steps will be generally applicable to other sequencing platforms. Journal of Biological Methods 2021-09-27 /pmc/articles/PMC8493558/ /pubmed/34631911 http://dx.doi.org/10.14440/jbm.2021.360 Text en © 2013-2021 The Journal of Biological Methods, All rights reserved. https://creativecommons.org/licenses/by-nc-sa/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License: http://creativecommons.org/licenses/by-nc-sa/4.0 |
spellingShingle | Article Pater, Adrian A. Bosmeny, Michael S. White, Adam A. Sylvain, Rourke J. Eddington, Seth B. Parasrampuria, Mansi Ovington, Katy N. Metz, Paige E. Yinusa, Abadat O. Barkau, Christopher L. Chilamkurthy, Ramadevi Benzinger, Scott W. Hebert, Madison. M. Gagnon, Keith T. High throughput nanopore sequencing of SARS-CoV-2 viral genomes from patient samples |
title | High throughput nanopore sequencing of SARS-CoV-2 viral genomes from patient samples |
title_full | High throughput nanopore sequencing of SARS-CoV-2 viral genomes from patient samples |
title_fullStr | High throughput nanopore sequencing of SARS-CoV-2 viral genomes from patient samples |
title_full_unstemmed | High throughput nanopore sequencing of SARS-CoV-2 viral genomes from patient samples |
title_short | High throughput nanopore sequencing of SARS-CoV-2 viral genomes from patient samples |
title_sort | high throughput nanopore sequencing of sars-cov-2 viral genomes from patient samples |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8493558/ https://www.ncbi.nlm.nih.gov/pubmed/34631911 http://dx.doi.org/10.14440/jbm.2021.360 |
work_keys_str_mv | AT pateradriana highthroughputnanoporesequencingofsarscov2viralgenomesfrompatientsamples AT bosmenymichaels highthroughputnanoporesequencingofsarscov2viralgenomesfrompatientsamples AT whiteadama highthroughputnanoporesequencingofsarscov2viralgenomesfrompatientsamples AT sylvainrourkej highthroughputnanoporesequencingofsarscov2viralgenomesfrompatientsamples AT eddingtonsethb highthroughputnanoporesequencingofsarscov2viralgenomesfrompatientsamples AT parasrampuriamansi highthroughputnanoporesequencingofsarscov2viralgenomesfrompatientsamples AT ovingtonkatyn highthroughputnanoporesequencingofsarscov2viralgenomesfrompatientsamples AT metzpaigee highthroughputnanoporesequencingofsarscov2viralgenomesfrompatientsamples AT yinusaabadato highthroughputnanoporesequencingofsarscov2viralgenomesfrompatientsamples AT barkauchristopherl highthroughputnanoporesequencingofsarscov2viralgenomesfrompatientsamples AT chilamkurthyramadevi highthroughputnanoporesequencingofsarscov2viralgenomesfrompatientsamples AT benzingerscottw highthroughputnanoporesequencingofsarscov2viralgenomesfrompatientsamples AT hebertmadisonm highthroughputnanoporesequencingofsarscov2viralgenomesfrompatientsamples AT gagnonkeitht highthroughputnanoporesequencingofsarscov2viralgenomesfrompatientsamples |